A detailed history of Physicians Financial Services, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Physicians Financial Services, Inc. holds 17,547 shares of AMGN stock, worth $4.62 Million. This represents 1.77% of its overall portfolio holdings.

Number of Shares
17,547
Previous 18,112 3.12%
Holding current value
$4.62 Million
Previous $5.66 Million 0.09%
% of portfolio
1.77%
Previous 1.84%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$309.38 - $337.38 $174,799 - $190,619
-565 Reduced 3.12%
17,547 $5.65 Million
Q2 2024

Aug 14, 2024

BUY
$262.75 - $319.31 $84,605 - $102,817
322 Added 1.81%
18,112 $5.66 Million
Q1 2024

May 10, 2024

SELL
$268.87 - $324.56 $7,259 - $8,763
-27 Reduced 0.15%
17,790 $5.06 Million
Q4 2023

Jan 26, 2024

SELL
$255.7 - $288.46 $3,835 - $4,326
-15 Reduced 0.08%
17,817 $5.13 Million
Q2 2023

Jul 26, 2023

SELL
$214.27 - $253.37 $25,712 - $30,404
-120 Reduced 0.67%
17,832 $3.96 Million
Q4 2022

Feb 09, 2023

BUY
$229.03 - $291.01 $45,806 - $58,202
200 Added 1.13%
17,952 $4.72 Million
Q3 2022

Oct 19, 2022

SELL
$224.46 - $253.15 $86,417 - $97,462
-385 Reduced 2.12%
17,752 $4 Million
Q2 2022

Aug 17, 2022

BUY
$230.71 - $256.74 $59,984 - $66,752
260 Added 1.45%
18,137 $4.41 Million
Q4 2021

Feb 02, 2022

SELL
$198.88 - $227.6 $38,980 - $44,609
-196 Reduced 1.08%
17,877 $4.02 Million
Q3 2021

Oct 27, 2021

BUY
$212.27 - $248.7 $853,749 - $1 Million
4,022 Added 28.62%
18,073 $3.84 Million
Q2 2021

Jul 27, 2021

SELL
$233.58 - $259.14 $267,449 - $296,715
-1,145 Reduced 7.53%
14,051 $3.43 Million
Q1 2021

May 21, 2021

BUY
$221.91 - $258.6 $142,022 - $165,504
640 Added 4.4%
15,196 $3.78 Million
Q4 2020

Feb 03, 2021

SELL
$216.38 - $257.67 $138,483 - $164,908
-640 Reduced 4.21%
14,556 $3.35 Million
Q3 2020

Nov 10, 2020

SELL
$234.65 - $260.95 $62,182 - $69,151
-265 Reduced 1.71%
15,196 $3.86 Million
Q2 2020

Jul 28, 2020

BUY
$197.81 - $242.74 $69,629 - $85,444
352 Added 2.33%
15,461 $3.65 Million
Q1 2020

Apr 27, 2020

BUY
$182.24 - $241.7 $2,733 - $3,625
15 Added 0.1%
15,109 $3.06 Million
Q3 2019

Nov 14, 2019

BUY
$174.11 - $208.62 $49,621 - $59,456
285 Added 1.92%
15,094 $2.92 Million
Q2 2019

Aug 12, 2019

BUY
$166.7 - $195.41 $306,561 - $359,358
1,839 Added 14.18%
14,809 $2.73 Million
Q1 2019

Apr 12, 2019

BUY
$180.87 - $203.88 $36,174 - $40,776
200 Added 1.57%
12,970 $2.46 Million
Q4 2018

Jan 22, 2019

BUY
$178.4 - $208.25 $274,736 - $320,705
1,540 Added 13.71%
12,770 $2.49 Million
Q3 2018

Nov 14, 2018

SELL
$185.29 - $208.89 $7,411 - $8,355
-40 Reduced 0.35%
11,230 $2.33 Million
Q2 2018

Aug 21, 2018

BUY
$166.05 - $186.51 $16,605 - $18,651
100 Added 0.9%
11,270 $2.08 Million
Q1 2018

Apr 17, 2018

BUY
$169.43 - $198.0 $137,238 - $160,380
810 Added 7.82%
11,170 $1.9 Million
Q4 2017

Feb 12, 2018

SELL
$168.79 - $188.59 $42,197 - $47,147
-250 Reduced 2.36%
10,360 $1.8 Million
Q3 2017

Nov 01, 2017

BUY
$167.29 - $191.0 $1.77 Million - $2.03 Million
10,610
10,610 $1.98 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Physicians Financial Services, Inc. Portfolio

Follow Physicians Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Physicians Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Physicians Financial Services, Inc. with notifications on news.